U.S. Markets open in 7 hrs 48 mins

SHAREHOLDER ALERT: FCAU and MMSI: Bronstein, Gewirtz & Grossman LLC Reminds Investors With Losses Exceeding $100K of Class Action Deadlines

NEW YORK, NY / ACCESSWIRE / January 16, 2020 / Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy of the Complaints by visiting the links below or you may contact Peretz Bronstein, Esq. or his Investor Relations Analyst, Yael Hurwitz of Bronstein, Gewirtz & Grossman, LLC at 212-697-6484. If you suffered a loss, you can request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. A lead plaintiff acts on behalf of all other class members in directing the litigation. The lead plaintiff can select a law firm of its choice. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Fiat Chrysler Automobiles N.V. (FCAU)

Class Period: February 26, 2016 - November 20, 2019

Deadline: January 31, 2020
For more info: www.bgandg.com/fcau

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) Fiat employed a bribery scheme to obtain favorable terms in its collective bargaining agreement with International Union, United Automobile, Aerospace and Agricultural Implement Workers of America; (2) high-ranking Fiat official were aware of and authorized the scheme; and (3) due to the foregoing, defendants' statements about Fiat's receivables, business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Merit Medical Systems, Inc. (MMSI)

Class Period: February 26, 2019 - October 30, 2019

Deadline: February 3, 2020
For more info: www.bgandg.com/mmsi

The complaint alleges that throughout the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) the integrations of Cianna and Vascular Insights, including their products, sales people, and R&D facilities, had caused operational disruptions and reduced sales and were months behind schedule; (2) sales of acquired company products had slowed substantially due to pre-acquisition pipeline fill, in particular for Vascular Insights products which, as late as July 2019, had zero orders during fiscal 2019; and (3) in light of the foregoing, the Company's reported financial guidance for fiscal 2019 and 2020 was made without a reasonable basis.

Contact:

Bronstein, Gewirtz & Grossman, LLC
Peretz Bronstein or Yael Hurwitz

212-697-6484 | info@bgandg.com

SOURCE: Bronstein, Gewirtz & Grossman, LLC



View source version on accesswire.com:
https://www.accesswire.com/571102/SHAREHOLDER-ALERT-FCAU-and-MMSI-Bronstein-Gewirtz-Grossman-LLC-Reminds-Investors-With-Losses-Exceeding-100K-of-Class-Action-Deadlines